Adherium Limited (ADR.AX)
AUD 0.01
(14.29%)
AUD 0.01
(14.29%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 840.98 Thousand AUD | -73.68% |
| 2023 | 3.19 Million AUD | 503.97% |
| 2022 | 529 Thousand AUD | 31.92% |
| 2021 | 401 Thousand AUD | -81.92% |
| 2020 | 2.21 Million AUD | -20.19% |
| 2019 | 2.77 Million AUD | -52.63% |
| 2018 | 5.86 Million AUD | 149.98% |
| 2017 | 2.34 Million AUD | 11.72% |
| 2016 | 2.1 Million AUD | -27.73% |
| 2015 | 2.9 Million AUD | 504.45% |
| 2014 | 480.93 Thousand AUD | -14.05% |
| 2013 | 559.52 Thousand AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | 840.98 Thousand AUD | -73.68% |
| 2024 Q4 | 463.8 Thousand AUD | 0.0% |
| 2024 Q2 | 377.18 Thousand AUD | 0.0% |
| 2023 FY | 3.19 Million AUD | 503.97% |
| 2023 Q4 | 1.97 Million AUD | 0.0% |
| 2023 Q2 | 1.22 Million AUD | 0.0% |
| 2022 Q4 | 332 Thousand AUD | 0.0% |
| 2022 FY | 529 Thousand AUD | 31.92% |
| 2022 Q2 | 197 Thousand AUD | 0.0% |
| 2021 Q2 | 243 Thousand AUD | 0.0% |
| 2021 Q4 | 158 Thousand AUD | 0.0% |
| 2021 FY | 401 Thousand AUD | -81.92% |
| 2020 Q2 | 1.41 Million AUD | 0.0% |
| 2020 Q4 | 803 Thousand AUD | 0.0% |
| 2020 FY | 2.21 Million AUD | -20.19% |
| 2019 FY | 2.77 Million AUD | -52.63% |
| 2019 Q4 | 1.79 Million AUD | 0.0% |
| 2019 Q2 | 986 Thousand AUD | 0.0% |
| 2018 Q4 | 3.2 Million AUD | 0.0% |
| 2018 Q2 | 2.66 Million AUD | 0.0% |
| 2018 FY | 5.86 Million AUD | 149.98% |
| 2017 Q2 | 1.38 Million AUD | 0.0% |
| 2017 FY | 2.34 Million AUD | 11.72% |
| 2017 Q4 | 961 Thousand AUD | 0.0% |
| 2016 FY | 2.1 Million AUD | -27.73% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 FY | 2.9 Million AUD | 504.45% |
| 2015 Q3 | - AUD | 0.0% |
| 2014 FY | 480.93 Thousand AUD | -14.05% |
| 2013 FY | 559.52 Thousand AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | 77.599% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 98.673% |
| Atomo Diagnostics Limited | 4.08 Million AUD | 79.421% |
| Anteris Technologies Ltd | 4.11 Million AUD | 79.544% |
| Control Bionics Limited | 5.12 Million AUD | 83.597% |
| CardieX Limited | 10.9 Million AUD | 92.289% |
| Compumedics Limited | 49.71 Million AUD | 98.309% |
| Cochlear Limited | 2.25 Billion AUD | 99.963% |
| CleanSpace Holdings Limited | 15.72 Million AUD | 94.651% |
| Cyclopharm Limited | 27.13 Million AUD | 96.901% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 92.504% |
| Nova Eye Medical Limited | 23.32 Million AUD | 96.395% |
| HeraMED Limited | 402.89 Thousand AUD | -108.734% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -36.619% |
| ImpediMed Limited | 10.31 Million AUD | 91.85% |
| InhaleRx Limited | 1.2 Million AUD | 30.154% |
| LBT Innovations Limited | 1.25 Million AUD | 33.043% |
| Micro-X Limited | 15.22 Million AUD | 94.475% |
| Neurotech International Limited | 1963.00 AUD | -42741.671% |
| OncoSil Medical Limited | 1.56 Million AUD | 46.276% |
| PolyNovo Limited | 103.19 Million AUD | 99.185% |
| Respiri Limited | 456.91 Thousand AUD | -84.057% |
| SomnoMed Limited | 91.65 Million AUD | 99.082% |
| Universal Biosensors, Inc. | 6.63 Million AUD | 87.321% |
| Uscom Limited | 3.72 Million AUD | 77.434% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | 90.3% |